Unknown NA INTERVENTIONAL 2-arm NCT04178759

Impact of Chemotherapy and Regenerative Markers of Liver Regeneration After Liver Resection for Liver Metastases (VULSK-Hep)

Impact of Chemotherapy and Regenerative Markers on Liver Regeneration After Liver Resection for Liver Metastases

Sponsor: Vilnius University

Conditions Liver Metastases Liver Regeneration

Updated 5 times since 2019 Last updated: Nov 25, 2019 Started: Sep 1, 2019 Primary completion: Apr 1, 2022 Completion: Apr 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04178759, this NA trial focuses on Liver Metastases and Liver Regeneration and remains ongoing. Sponsored by Vilnius University, it has been updated 5 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
May 2022 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — May 2022 [monthly]

Recruiting NA
Dec 2019 — Jan 2021 [monthly]

Recruiting NA

First recorded

Sep 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Vilnius University

Data source: Vilnius University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vilnius, Lithuania